Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Bekkering

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hepatology (Baltimore, Md.)|December 16, 1997
Hepatitis C: viral kineticsF C Bekkering, J T Brouwer, S W Schalm, et al.
Journal of Hepatology|April 27, 2001
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirinF C Bekkering, J T Brouwer, B E Hansen, et al.
Journal of Hepatology|January 6, 2000
New treatment strategies in non-responder patients with chronic hepatitis CS W Schalm, J T Brouwer, F C Bekkering, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical modelF C Bekkering, C Stalgis, J G McHutchison, et al.
Journal of Viral Hepatitis|May 20, 2003
High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapyJ M Vrolijk, F C Bekkering, J T Brouwer, et al.
BMC Gastroenterology|January 22, 2002
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control studyF C Bekkering, A U Neumann, J T Brouwer, et al.
Journal of Hepatology|July 22, 1998
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapyF C Bekkering, J T Brouwer, G Leroux-Roels, et al.
Gastroenterology|July 13, 2000
Acute pancreatitis attributed to the use of interferon alfa-2bI A Eland, M C Rasch, M J Sturkenboom, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2009
Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intentionE J R De Graaf, P G Doornebosch, R A E M Tollenaar, et al.
BMC Gastroenterology|December 13, 2022
Long-term oncological outcomes of endoscopic full-thickness resection after previous incomplete resection of low-risk T1 CRC (LOCAL-study): study protocol of a national prospective cohort studyL W Zwager, L M G Moons, A Farina Sarasqueta, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|December 16, 1997
Hepatitis C: viral kineticsF C Bekkering, J T Brouwer, S W Schalm, et al.
Journal of Hepatology|April 27, 2001
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirinF C Bekkering, J T Brouwer, B E Hansen, et al.
Journal of Hepatology|January 6, 2000
New treatment strategies in non-responder patients with chronic hepatitis CS W Schalm, J T Brouwer, F C Bekkering, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical modelF C Bekkering, C Stalgis, J G McHutchison, et al.
Journal of Viral Hepatitis|May 20, 2003
High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapyJ M Vrolijk, F C Bekkering, J T Brouwer, et al.
BMC Gastroenterology|January 22, 2002
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control studyF C Bekkering, A U Neumann, J T Brouwer, et al.
Journal of Hepatology|July 22, 1998
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapyF C Bekkering, J T Brouwer, G Leroux-Roels, et al.
Gastroenterology|July 13, 2000
Acute pancreatitis attributed to the use of interferon alfa-2bI A Eland, M C Rasch, M J Sturkenboom, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2009
Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intentionE J R De Graaf, P G Doornebosch, R A E M Tollenaar, et al.
BMC Gastroenterology|December 13, 2022
Long-term oncological outcomes of endoscopic full-thickness resection after previous incomplete resection of low-risk T1 CRC (LOCAL-study): study protocol of a national prospective cohort studyL W Zwager, L M G Moons, A Farina Sarasqueta, et al.
Pageof 1